List of Contents

Vaccines Market Size, Share, and Trends 2024 to 2033

Vaccines Market (By Type: Recombinant/conjugate/Subunit, Inactivated, Live Attenuated, Viral Vector, mRNA, Toxoid, Others; By Route of Administration: Parenteral, Oral; By Disease Indication: Viral Diseases, Bacterial Diseases; By Age Group: Pediatric, Adults; By Distribution Channel: Hospital & Retail Pharmacies, Government Suppliers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

  • Last Updated : May 2024
  • Report Code : 4339
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Vaccines Market 

5.1. COVID-19 Landscape: Vaccines Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Vaccines Market, By Type

8.1. Vaccines Market Revenue and Volume, by Type, 2024-2033

8.1.1. Recombinant/conjugate/Subunit

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Inactivated

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Live Attenuated

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

8.1.4. Viral Vector

8.1.4.1. Market Revenue and Volume Forecast (2021-2033)

8.1.5. mRNA

8.1.5.1. Market Revenue and Volume Forecast (2021-2033)

8.1.6. Toxoid

8.1.6.1. Market Revenue and Volume Forecast (2021-2033)

8.1.7. Others

8.1.7.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Vaccines Market, By Route of Administration

9.1. Vaccines Market Revenue and Volume, by Route of Administration, 2024-2033

9.1.1. Parenteral

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Oral

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Vaccines Market, By Disease Indication 

10.1. Vaccines Market Revenue and Volume, by Disease Indication, 2024-2033

10.1.1. Viral Diseases

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Bacterial Diseases

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global Vaccines Market, By Age Group

11.1. Vaccines Market Revenue and Volume, by Age Group, 2024-2033

11.1.1. Pediatric

11.1.1.1. Market Revenue and Volume Forecast (2021-2033)

11.1.2. Adults

11.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 12. Global Vaccines Market, By Distribution Channel

12.1. Vaccines Market Revenue and Volume, by Distribution Channel, 2024-2033

12.1.1. Hospital & Retail Pharmacies

12.1.1.1. Market Revenue and Volume Forecast (2021-2033)

12.1.2. Government Suppliers

12.1.2.1. Market Revenue and Volume Forecast (2021-2033)

12.1.3. Others

12.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 13. Global Vaccines Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Type (2021-2033)

13.1.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

13.1.3. Market Revenue and Volume Forecast, by Disease Indication (2021-2033)

13.1.4. Market Revenue and Volume Forecast, by Age Group (2021-2033)

13.1.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)

13.1.6.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

13.1.6.3. Market Revenue and Volume Forecast, by Disease Indication (2021-2033)

13.1.6.4. Market Revenue and Volume Forecast, by Age Group (2021-2033)

13.1.6.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)

13.1.7.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

13.1.7.3. Market Revenue and Volume Forecast, by Disease Indication (2021-2033)

13.1.7.4. Market Revenue and Volume Forecast, by Age Group (2021-2033)

13.1.7.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Type (2021-2033)

13.2.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

13.2.3. Market Revenue and Volume Forecast, by Disease Indication (2021-2033)

13.2.4. Market Revenue and Volume Forecast, by Age Group (2021-2033) 

13.2.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033) 

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)

13.2.6.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

13.2.6.3. Market Revenue and Volume Forecast, by Disease Indication (2021-2033)

13.2.7. Market Revenue and Volume Forecast, by Age Group (2021-2033) 

13.2.8. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033) 

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Type (2021-2033)

13.2.9.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

13.2.9.3. Market Revenue and Volume Forecast, by Disease Indication (2021-2033)

13.2.10. Market Revenue and Volume Forecast, by Age Group (2021-2033)

13.2.11. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Type (2021-2033)

13.2.12.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

13.2.12.3. Market Revenue and Volume Forecast, by Disease Indication (2021-2033)

13.2.12.4. Market Revenue and Volume Forecast, by Age Group (2021-2033)

13.2.13. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Type (2021-2033)

13.2.14.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

13.2.14.3. Market Revenue and Volume Forecast, by Disease Indication (2021-2033)

13.2.14.4. Market Revenue and Volume Forecast, by Age Group (2021-2033)

13.2.15. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Type (2021-2033)

13.3.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

13.3.3. Market Revenue and Volume Forecast, by Disease Indication (2021-2033)

13.3.4. Market Revenue and Volume Forecast, by Age Group (2021-2033)

13.3.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)

13.3.6.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

13.3.6.3. Market Revenue and Volume Forecast, by Disease Indication (2021-2033)

13.3.6.4. Market Revenue and Volume Forecast, by Age Group (2021-2033)

13.3.7. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Type (2021-2033)

13.3.8.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

13.3.8.3. Market Revenue and Volume Forecast, by Disease Indication (2021-2033)

13.3.8.4. Market Revenue and Volume Forecast, by Age Group (2021-2033)

13.3.9. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Type (2021-2033)

13.3.10.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

13.3.10.3. Market Revenue and Volume Forecast, by Disease Indication (2021-2033)

13.3.10.4. Market Revenue and Volume Forecast, by Age Group (2021-2033)

13.3.10.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Type (2021-2033)

13.3.11.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

13.3.11.3. Market Revenue and Volume Forecast, by Disease Indication (2021-2033)

13.3.11.4. Market Revenue and Volume Forecast, by Age Group (2021-2033)

13.3.11.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)

13.4.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

13.4.3. Market Revenue and Volume Forecast, by Disease Indication (2021-2033)

13.4.4. Market Revenue and Volume Forecast, by Age Group (2021-2033)

13.4.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)

13.4.6.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

13.4.6.3. Market Revenue and Volume Forecast, by Disease Indication (2021-2033)

13.4.6.4. Market Revenue and Volume Forecast, by Age Group (2021-2033)

13.4.7. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Type (2021-2033)

13.4.8.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

13.4.8.3. Market Revenue and Volume Forecast, by Disease Indication (2021-2033)

13.4.8.4. Market Revenue and Volume Forecast, by Age Group (2021-2033)

13.4.9. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Type (2021-2033)

13.4.10.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

13.4.10.3. Market Revenue and Volume Forecast, by Disease Indication (2021-2033)

13.4.10.4. Market Revenue and Volume Forecast, by Age Group (2021-2033)

13.4.10.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Type (2021-2033)

13.4.11.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

13.4.11.3. Market Revenue and Volume Forecast, by Disease Indication (2021-2033)

13.4.11.4. Market Revenue and Volume Forecast, by Age Group (2021-2033)

13.4.11.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)

13.5.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

13.5.3. Market Revenue and Volume Forecast, by Disease Indication (2021-2033)

13.5.4. Market Revenue and Volume Forecast, by Age Group (2021-2033)

13.5.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)

13.5.6.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

13.5.6.3. Market Revenue and Volume Forecast, by Disease Indication (2021-2033)

13.5.6.4. Market Revenue and Volume Forecast, by Age Group (2021-2033)

13.5.7. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Type (2021-2033)

13.5.8.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

13.5.8.3. Market Revenue and Volume Forecast, by Disease Indication (2021-2033)

13.5.8.4. Market Revenue and Volume Forecast, by Age Group (2021-2033)

13.5.8.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

Chapter 14. Company Profiles

14.1. GSK plc

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Merck & Co Inc

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Pfizer Inc

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Sanofi

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. CSL (Australia), Emergent

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Johnson and Johnson Services, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Astrazeneca

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Serum Institute of India Pvt Ltd

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Bavarian Nordic

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Mitsubishi Tanabe Pharma Corporation

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global vaccines market size is expected to increase USD 152.45 billion by 2033 from USD 81.06 billion in 2023.

The global vaccines market will register growth rate of 6.52% between 2024 and 2033.

The major players operating in the vaccines market are GSK plc, Merck & Co Inc, Pfizer Inc, Sanofi, CSL (Australia), Emergent, Johnson and Johnson Services, Inc., AstraZeneca, Serum Institute of India Pvt Ltd, Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Company, Limited, Panacea Biotec, Biological E Ltd., Bharat Biotech, Novavax, Inovio Pharmaceuticals, Sinovac, Incepta Pharma, Valneva Se, VBI Vaccines Inc, Bio Farma, FSUE NPO MICROGEN, Zhi Fei Biological, Indian Immunologicals Ltd, and Others.

The driving factors of the vaccines market are the growing global health security initiatives and rapid vaccine development and production scalability.

North America region will lead the global vaccines market during the forecast period 2024 to 2033.

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Plan your call and get expert insights!

Schedule a Meeting Schedule a Meeting

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us